Literature DB >> 19214098

An assessment of the reliability of the Enneking and Weinstein-Boriani-Biagini classifications for staging of primary spinal tumors by the Spine Oncology Study Group.

Patrick Chan1, Stefano Boriani, Daryl R Fourney, Roberto Biagini, Mark B Dekutoski, Michael G Fehlings, Timothy C Ryken, Ziya L Gokaslan, Frank D Vrionis, James S Harrop, Meic H Schmidt, Luis R Vialle, Peter C Gerszten, Laurence D Rhines, Stephen L Ondra, Stuart R Pratt, Charles G Fisher.   

Abstract

STUDY
DESIGN: Reliability analysis based on expert panel case series review and grading per the Enneking and Weinstein-Boriani-Biagini classification systems.
OBJECTIVE: To assess the reliability of the Enneking and Weinstein-Boriani-Biagini classification systems. SUMMARY OF BACKGROUND DATA: The Enneking and Weinstein-Boriani-Biagini (WBB) classifications were developed to stage and facilitate treatment planning in patients with primary spine tumors. To date, their interobserver and intraobserver reliability has not been assessed-a fundamental step in facilitating broader clinical and research use.
METHODS: Clinical information, imaging studies, and biopsy results were compiled from 15 selected patients with primary spinal tumors. Eighteen spine surgeons independently estimated and scored the cases for Enneking grade, tumor and metastasis categories, Enneking stage, Enneking-recommended surgical margin, WBB zones and layers, and WBB-recommended surgical procedures, with a second assessment performed after random resorting of cases. Interobserver and intraobserver reliability of each category were assessed by percent agreement or proportional overlap. The Fleiss, Cohen, and Mezzich kappa statistics (kappa) were then applied, determined by the type of variable analyzed.
RESULTS: The kappa statistics for interobserver reliability were 0.82, 0.22, 0.00, 0.57, 0.47, 0.31, 0.58, and 0.54 for the fields of Enneking grade, tumor and metastasis categories, Enneking stage, Enneking-recommended surgical margin, WBB zones and layers, and WBB-recommended surgical procedures, respectively. The kappa statistics for intraobserver reliability were 0.97, 0.53, 0.47, 0.82, 0.67, 0.63, 0.79, and 0.79 for the same respective fields. According to Landis and Koch, the ranges of kappa values of 0.00 to 0.20, 0.21 to 0.40, 0.41 to 0.60, 0.61 to 0.80, and >0.80 imply slight, fair, moderate, substantial, and near-perfect agreement, respectively.
CONCLUSION: Results indicate moderate interobserver reliability and substantial and near-perfect intraobserver reliability for both the Enneking and WBB classification in terms of staging and guidance for treatment, despite a less than moderate interobserver reliability in interpreting the Enneking local tumor extension and WBB sector. Before incorporating the classifications in the clinical practice and research studies, further work is required to investigate the validity of the classifications.

Entities:  

Mesh:

Year:  2009        PMID: 19214098     DOI: 10.1097/BRS.0b013e3181971283

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  15 in total

Review 1.  Staging and treatment of osteoblastoma in the mobile spine: a review of 51 cases.

Authors:  Stefano Boriani; L Amendola; S Bandiera; C E Simoes; M Alberghini; M Di Fiore; A Gasbarrini
Journal:  Eur Spine J       Date:  2012-06-14       Impact factor: 3.134

2.  In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system.

Authors:  Muhammad Umar Jawad; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2010-07       Impact factor: 4.176

3.  En bloc resection in the spine: a procedure of surgical oncology.

Authors:  Stefano Boriani
Journal:  J Spine Surg       Date:  2018-09

Review 4.  Current trends in mini-invasive management of spine metastases.

Authors:  Gianluigi Guarnieri; Roberto Izzo; Mario Muto
Journal:  Interv Neuroradiol       Date:  2015-05-11       Impact factor: 1.610

5.  Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.

Authors:  Ziya L Gokaslan; Patricia L Zadnik; Daniel M Sciubba; Niccole Germscheid; C Rory Goodwin; Jean-Paul Wolinsky; Chetan Bettegowda; Mari L Groves; Alessandro Luzzati; Laurence D Rhines; Charles G Fisher; Peter Pal Varga; Mark B Dekutoski; Michelle J Clarke; Michael G Fehlings; Nasir A Quraishi; Dean Chou; Jeremy J Reynolds; Richard P Williams; Norio Kawahara; Stefano Boriani
Journal:  J Neurosurg Spine       Date:  2015-12-18

6.  Neoadjuvant denosumab for the treatment of a sacral osteoblastoma.

Authors:  Jeremy J Reynolds; Dominique A Rothenfluh; Nick Athanasou; Shaun Wilson; David C Kieser
Journal:  Eur Spine J       Date:  2018-01-22       Impact factor: 3.134

7.  Long-term outcomes in primary spinal osteochondroma: a multicenter study of 27 patients.

Authors:  Daniel M Sciubba; Mohamed Macki; Mohamad Bydon; Niccole M Germscheid; Jean-Paul Wolinsky; Stefano Boriani; Chetan Bettegowda; Dean Chou; Alessandro Luzzati; Jeremy J Reynolds; Zsolt Szövérfi; Patti Zadnik; Laurence D Rhines; Ziya L Gokaslan; Charles G Fisher; Peter Paul Varga
Journal:  J Neurosurg Spine       Date:  2015-03-20

Review 8.  Aneurysmal bone cyst of C2 treated with novel anterior reconstruction and stabilization.

Authors:  S Rajasekaran; Siddharth N Aiyer; Ajoy Prasad Shetty; Rishi Kanna; Anupama Maheswaran
Journal:  Eur Spine J       Date:  2016-03-23       Impact factor: 3.134

9.  Risk Factors for Recurrence of Surgically Treated Conventional Spinal Schwannomas: Analysis of 169 Patients From a Multicenter International Database.

Authors:  Michael G Fehlings; Anick Nater; Juan J Zamorano; Lindsay A Tetreault; Peter P Varga; Ziya L Gokaslan; Stefano Boriani; Charles G Fisher; Laurence Rhines; Chetan Bettegowda; Norio Kawahara; Dean Chou
Journal:  Spine (Phila Pa 1976)       Date:  2016-03       Impact factor: 3.468

10.  Spinal chondrosarcoma: a review.

Authors:  Pavlos Katonis; Kalliopi Alpantaki; Konstantinos Michail; Stratos Lianoudakis; Zaharias Christoforakis; George Tzanakakis; Apostolos Karantanas
Journal:  Sarcoma       Date:  2011-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.